IRIS
Paciotti, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.513
NA - Nord America 2.160
SA - Sud America 748
EU - Europa 525
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 70
OC - Oceania 8
Totale 6.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.053
SG - Singapore 1.386
BR - Brasile 585
CN - Cina 451
VN - Vietnam 389
IT - Italia 151
HK - Hong Kong 77
AR - Argentina 74
DE - Germania 51
FI - Finlandia 51
FR - Francia 47
GB - Regno Unito 47
CA - Canada 42
IE - Irlanda 42
IN - India 38
BD - Bangladesh 35
MX - Messico 33
EC - Ecuador 31
ID - Indonesia 27
NG - Nigeria 21
NL - Olanda 20
RU - Federazione Russa 20
ZA - Sudafrica 18
IQ - Iraq 16
UA - Ucraina 16
VE - Venezuela 14
CO - Colombia 13
PK - Pakistan 11
SE - Svezia 11
AT - Austria 10
CL - Cile 10
TR - Turchia 10
PL - Polonia 9
PY - Paraguay 9
AU - Australia 8
JP - Giappone 8
MO - Macao, regione amministrativa speciale della Cina 8
UY - Uruguay 8
ES - Italia 7
TN - Tunisia 7
CH - Svizzera 6
EG - Egitto 6
JM - Giamaica 6
MY - Malesia 6
UZ - Uzbekistan 6
DZ - Algeria 5
GT - Guatemala 5
NP - Nepal 5
RO - Romania 5
SA - Arabia Saudita 5
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
DO - Repubblica Dominicana 4
IL - Israele 4
JO - Giordania 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
TH - Thailandia 3
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LT - Lituania 2
PH - Filippine 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
KW - Kuwait 1
LC - Santa Lucia 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 6.024
Salva come PNG Salva come JPEG
Città #
Singapore 442
Ashburn 253
San Jose 210
Dallas 174
Beijing 145
Ho Chi Minh City 134
Council Bluffs 130
The Dalles 117
Hanoi 89
Shanghai 81
Wilmington 74
Hong Kong 70
New York 67
Chandler 62
Santa Clara 59
Milan 58
Los Angeles 53
Helsinki 51
Dublin 43
São Paulo 42
San Mateo 40
Ann Arbor 31
Princeton 30
Boardman 28
Lawrence 24
Paris 24
Rio de Janeiro 24
Da Nang 23
Benin City 21
Buffalo 18
Orem 18
Phoenix 17
Haiphong 16
Leawood 16
Mexico City 15
Guayaquil 14
Hải Dương 13
Montreal 13
Amsterdam 12
Camden 12
London 12
Naples 12
Belo Horizonte 11
Johannesburg 11
Rome 11
Seattle 11
Toronto 11
Brooklyn 10
Chicago 10
Thái Bình 10
Brasília 9
Curitiba 9
Fairfield 9
Warsaw 9
Boston 8
Buenos Aires 8
Frankfurt am Main 8
Philadelphia 8
Porto Alegre 8
Biên Hòa 7
Cincinnati 7
Goiânia 7
Manaus 7
Quito 7
Salvador 7
Beachwood 6
Figino 6
Houston 6
Las Vegas 6
Montevideo 6
Osasco 6
Secaucus 6
Woodbridge 6
Asunción 5
Atlanta 5
Baghdad 5
Campinas 5
Charlotte 5
Chennai 5
Feira de Santana 5
Guarulhos 5
Hortolândia 5
Istanbul 5
Manchester 5
Miami 5
Mumbai 5
Nuremberg 5
Phủ Lý 5
Sacramento 5
San Diego 5
São Gonçalo 5
São José do Rio Preto 5
Tashkent 5
Tokyo 5
Uberlândia 5
Amman 4
Baku 4
Brescia 4
Bến Tre 4
Cairo 4
Totale 3.168
Salva come PNG Salva come JPEG
Nome #
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 114
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 114
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 96
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 93
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 92
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 90
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 90
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 90
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 89
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 86
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 84
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 82
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 79
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis 78
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study 77
Effects of a home-based pelvic floor muscle training with and without action and cue observation on urinary incontinence after prostatectomy: A randomized controlled trial 75
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience 75
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma 75
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer 75
En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study 73
External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era 71
A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies 70
Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging 69
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes 66
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 65
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story 64
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic? 64
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer 63
Gender-specific risk factors for renal cell carcinoma: a systematic review 63
Systematic Review and Clinical Outcomes of new Robotic Systems in Urology 62
ROBOT-ASSISTED PARTIAL NEPHRECTOMY: TECHNIQUES AND OUTCOMES FROM THE TRANSATLANTIC ROBOTIC NEPHRON-SPARING SURGERY (TRONES) STUDY GROUP 61
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study 61
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis 60
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer in the initial biopsy setting 59
IN VITRO AND IN VIVO NEW EVIDENCE FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE: OPTIMIZATION OF THE STONE FREE RATE (SFR) AFTER RIRS 59
A cost analysis in implementing simulation-based training into a novel urology curriculum 58
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure 57
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer 56
Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study 55
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes? 55
New horizons in gynecological surgery: first-year experience with HUGO™ robotic-assisted surgery system at two tertiary referral robotic centers 55
Assessing the relationship between micro-ultrasound results and pathology at radical prostatectomy 55
Assessment of the diagnostic accuracy of microultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional preliminary experience 54
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial 54
THE UTILITY OF MICRO-ULTRASOUND IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER: A PRIAS STUDY EXTENSION 54
Enhanced diagnostic accuracy of micro-ultrasound in prostate cancer detection: An updated series from a single-center prospective study 53
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes 53
Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer 52
Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis 51
International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity 51
Reply by Authors 50
Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancer 48
A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer 48
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration 47
Assessment of face and content validity of performance metrics for basic robotic surgery skills PBP curriculum: a J-ERUS/YAU consensus on dry-lab training models 47
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center 46
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers 46
Comparison between the diagnostic accuracy of high resolution micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: Preliminary results from a single-institutional ongoing prospective trial 45
Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer 45
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic 45
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional experience 45
Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers 45
Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment? 45
Surgical Complications Requiring Intervention in Open versus Minimally Invasive Radical Prostatectomy 44
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride 44
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 44
Machine learning driven diagnostic pathway for clinically significant prostate cancer: the role of micro-ultrasound 43
High resolution micro-ultrasound imaging for bladder cancer: A gender and stage-oriented assessment. VIDEO 43
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy 43
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 42
Will Renorrhaphy Become Obsolete? Evaluation of a New Hemostatic Sealant 42
Profiling of the immune microenvironment in prostate cancer at single cell level 42
Current Landscape of Surgical Assessment Models in Urology Residency Training. Letter 42
HEAD-TO-HEAD COMPARISON BETWEEN MICRO-ULTRASOUND AND MRI IN THE DIFFERENTIATION BETWEEN MUSCLE-INVASIVE AND NON-MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM THE BLADDER MICROUS VERSUS MRI CANCER IMAGING STAGING STUDY (BUS-MISS) PROTOCOL 41
Temporal Trends in the Incidence of Testicular Cancer in the United States over the Past Four Decades 40
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative study 40
Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots 40
Where Do Micro-Ultrasound and MRI Find Prostate Cancer? A Target Localization Study 39
MP36-20 POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER 39
A comparative analysis of the HUGOTM robot-assisted surgery system and the Da Vinci® Xi surgical system for robot-assisted sacrocolpopexy for pelvic organ prolapse treatment 39
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis 38
Beyond the price tag: reassessing the value of robotic surgery in urologic oncology 38
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system 38
Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis 38
Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer 37
Improving Augmented Reality Through Deep Learning: Real-time Instrument Delineation in Robotic Renal Surgery 37
Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center 36
UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion 36
Robot-Assisted Sacropexy with the Novel HUGO Robot-Assisted Surgery System: Initial Experience and Surgical Setup at a Tertiary Referral Robotic Center 35
Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events 35
Transitioning from Da Vinci Si to Xi: assessing surgical outcomes at a high-volume robotic center 35
Development and validation of metrics for a new RAPN training model 34
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer 34
Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma 34
Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinoma 34
Robot-assisted simple prostatectomy with the novel HUGO™ RAS System: feasibility, setting, and perioperative outcomes 33
Robot-Assisted Pyeloplasty with HUGO™ Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center 33
European training in urology (ENTRY): quality-assured training for European urology residents 33
Transforming hostile abdomen management: the rise of single-port for retroperitoneal robot-assisted partial nephrectomy 33
Proficiency-based Progression Training: A Scientific Approach to Learning Surgical Skills 32
Totale 5.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022124 0 9 1 23 0 1 7 17 18 12 33 3
2022/2023282 51 4 28 24 23 16 7 19 37 31 35 7
2023/2024279 21 22 55 10 11 44 17 26 2 8 21 42
2024/2025882 19 2 21 15 4 65 35 48 113 143 128 289
2025/20263.919 457 255 363 662 231 164 668 214 235 267 179 224
2026/2027507 258 249 0 0 0 0 0 0 0 0 0 0
Totale 6.162